Skip to main content
. 2018 Oct 20;8(5):282–291.

Figure 4.

Figure 4

Comparison of cRGD-ZW800-1 and ZW800F-cRGD-DFO. A: The TBRs obtained with the ZW800F-cRGD-Zr-DFO were significantly higher at 24 h post injection (P=0.03). B: Tumor-specific signals of ZW800F-cRGD-DFO remained above 50% for up to 2 days after injection and detectable up to 7 days after injection. C: Organ-to-tumor ratios of cRGD-ZW800-1 compared to ZW800F-cRGD-Zr-DFO at 24 h after injection. The ratios are lower and more favorable for ZW800F-cRGD-Zr-DFO. *: significant differences.